Email this pageWelcome
The University of Rochester Clinical and Translational Science Institute is one of 38 institutions nationwide with funding from the National Institutes of Health to lead the emerging field of clinical and translational research. The Institute is building the foundation to assist researchers at the UR and across Upstate New York to produce innovative technology and methods that more efficiently and more quickly advance treatments to patients.
The goals of the CTSI include: increased funds for pilot projects and faculty training; enhanced services for data management, computer simulation, biostatistics, epidemiology, research ethics, and community involvement; new Master's and Doctoral degree programs in clinical and translational science; and the formation of a network of hospitals and biomedical research institutions in Upstate New York whose members will collaborate on projects and share resources.
NIH Funding Acknowledgement
Support for the University of Rochester Clinical and Translational Science Institute primarily comes from Grant Numbers UL1 RR024160, KL2 RR024136, and TL1 RR024135 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), and the NIH Roadmap for Medical Research. The contents of this website are solely the responsibility of the University of Rochester and do not necessarily represent the official view of NCRR or NIH. Information on NCRR is available at www.ncrr.nih.gov/.
Information on Re-engineering the Clinical Research Enterprise can be obtained from http://nihroadmap.nih.gov/clinicalresearch/overview-translational.asp.
